乾眼症治療設備市場規模、佔有率和成長分析：按技術、應用、便攜性、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球乾眼症治療設備市場價值為 2.897 億美元，預計到 2025 年將成長至 3.1172 億美元，到 2033 年將成長至 5.6009 億美元，在預測期（2026-2033 年）內複合年成長率為 7.6%。

由於人口老化和生活方式的改變導致乾眼症盛行率不斷上升，全球乾眼症治療設備市場正經歷顯著成長。該市場涵蓋多種診斷和治療設備，例如淚液分析系統、瞼板腺熱脈衝治療系統、強烈脈衝光 (IPL) 治療平台以及微創閉塞植入。技術進步正在提高診斷準確性和治療效果，增強醫療專業人員的信心，並推動患者需求。淚液滲透壓分析和高解析度瞼板腺成像等創新技術能夠實現精準的疾病分類，為熱脈衝治療和強脈衝光等有效治療方法鋪路。此外，人工智慧透過整合多種數據輸入來提高診斷的準確性和標準化程度，從而革新診斷方式，最終簡化工作流程，並增強臨床醫生對這個以有效且可重複的治療結果為核心的市場的信心。

全球乾眼症治療設備市場按技術、應用、便攜性、最終用戶、分銷管道和地區進行細分。按技術分類，市場可分為熱脈衝治療設備、強脈衝光 (IPL) 設備、寬頻光 (BBL) 配備、瞼板腺擠壓 (MGX) 系統、聯合治療設備（IPL + MGX/熱脈衝 + 擠壓）、低功率瞼緣治療 (LLLT) 設備、射頻 (RF) 設備、神經刺激設備、淚點阻塞設備、其他眼瞼炎設備和其他裝置。按應用分類，市場可分為瞼板腺功能障礙 (MGD) 的治療、蒸發乾眼症的治療、淚液缺乏型乾眼症的治療、眼瞼炎相關性乾眼症的治療以及眼表炎症的治療。依便攜性分類，市場可分為獨立式臨床系統、手持/可攜式設備和家用設備。按最終用戶分類，市場細分為醫院、眼科診所、驗光診所、門診手術中心 (ASC) 和居家照護環境。依分銷通路分類，銷售額分為直銷、批發商/分銷商及線上銷售管道。按地區分類，銷售額分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球乾眼治療設備市場的成長要素

隨著越來越多的人尋求臨床支持以控制症狀，乾眼症盛行率的上升顯著推動了對診斷和治療設備的需求。乾眼症帶來的不適感開始影響日常生活，醫療專業人員正加強識別和治療該疾病，促使醫療機構投資購買專用設備，即便這些投資並非事先規劃。人們對乾眼症管理的日益關注，使其重要性得到更廣泛的認可，並自然而然地帶動了設備採購方面的投資。因此，製造商更有動力創新，開發更人性化的解決方案，從而形成良性循環，促進產品的持續研發和商業化，確保產品供應，並有效滿足不斷成長的臨床需求。

全球乾眼症治療設備市場的限制因素

由於先進治療設備的高成本，全球乾眼症治療設備市場面臨許多限制。這種經濟負擔限制了診所和患者的接受度，尤其是預算有限的患者，也為提供價格合理的治療方案帶來了挑戰。因此，採購決策往往被拖延，阻礙了這些解決方案的廣泛應用。小規模的醫療機構可能會選擇推遲對專業設備的投資，轉而選擇更保守的治療方法。這進一步限制了設備在不同醫療機構中的普及。此外，成本敏感性會影響醫保報銷的討論，並最終影響醫療機構的採購決策。因此，市場滲透率不均衡，製造商面臨更大的壓力，需要證明產品的價值並提供彈性價格設定方案。

全球乾眼症治療設備市場趨勢

由於遠端醫療醫療模式的興起，全球乾眼症治療設備市場正經歷重大變革。遠端後續觀察和連網診斷工具的出現，為患者提供了更方便有效的乾眼症管理方案。這種轉變使得臨床醫生能夠透過數位平台遠端進行初步症狀篩檢、調整設備使用情況並監測治療依從性，從而實現個人化護理和及時干預。家用設備的日益普及正在消除患者就診專科醫生的傳統障礙，並促進驗光師和眼科醫生之間的協作治療。最終，這一趨勢提高了患者的便利性，並改善了不同患者群體的長期治療效果。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球乾眼症治療設備市場規模：依技術分類

• 熱脈衝裝置
• IPL（強烈脈衝光）治療儀
• 寬頻光（BBL）設備
• 瞼板腺擠壓（MGX）系統
• 聯合治療設備（IPL + MGX / 熱療 + 加壓）
• 低功率光療（LLLT）設備
• 射頻（RF）設備
• 神經刺激裝置
• 淚小點阻塞裝置
• 眼瞼清創和眼瞼炎治療裝置
• 其他

全球乾眼治療設備市場規模：依應用領域分類

• 瞼板腺功能障礙（MGD）的治療
• 治療蒸發性乾眼症
• 治療缺水性乾眼症
• 眼瞼炎相關乾眼症的治療
• 眼表發炎的治療

全球乾眼症治療設備市場規模：可攜式

• 獨立臨床系統
• 手持/可攜式設備
• 家用設備

全球乾眼症治療設備市場規模：依最終用戶分類

• 醫院
• 眼科診所
• 眼科檢查診所
• 門診手術中心（ASC）
• 居家醫療環境

全球乾眼症治療設備市場規模：依通路分類

• 直銷
• 銷售代理商和經銷商
• 線上銷售管道

全球乾眼症治療設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Lumenis Be Ltd.
• Johnson & Johnson Vision Care, Inc.
• Alcon Inc.
• Bausch+Lomb Corporation
• Sight Sciences, Inc.
• TearScience, Inc.
• ESW Vision Ltd.
• Nidek Co., Ltd.
• Topcon Corporation
• Carl Zeiss Meditec AG
• AbbVie Inc.
• Quantel Medical SAS
• Optima Medical Ltd.
• IRIDEX Corporation
• Eyevance Pharmaceuticals LLC
• Aequus Pharmaceuticals Inc.
• OCuSOFT Inc.
• MiBo Medical Group
• NuSight Medical Ltd.
• Bruder Healthcare Company LLC

結論與建議

Global Dry Eye Treatment Devices Market size was valued at USD 289.7 Million in 2024 and is poised to grow from USD 311.72 Million in 2025 to USD 560.09 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global dry eye treatment devices market is experiencing significant growth due to the rising prevalence of dry eye disease, driven by demographic aging and lifestyle changes. This market encompasses various diagnostic and therapeutic devices, including tear film analyzers, meibomian gland thermal pulsation systems, intense pulsed light platforms, and minimally invasive occlusive implants. Technological advancements enhance diagnostic precision and therapeutic efficacy, fostering clinician trust and increasing patient demand. Innovations such as tear osmolarity testing and high-resolution meibography enable accurate disease categorization, paving the way for effective treatments like thermal pulsation and intense pulsed light. Additionally, AI is revolutionizing diagnosis by integrating multiple data inputs to improve accuracy and standardization, ultimately streamlining workflows and enhancing clinician confidence in a market focused on effective, repeatable outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dry Eye Treatment Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dry Eye Treatment Devices Market Segments Analysis

The global dry eye treatment devices market is segmented by technology, application, portability, end user, distribution channel and region. Based on technology, the market is segmented into Thermal Pulsation Devices, Intense Pulsed Light (IPL) Devices, Broadband Light (BBL) Devices, Meibomian Gland Expression (MGX) Systems, Combination Therapy Devices (IPL + MGX / Heat + Expression), Low-Level Light Therapy (LLLT) Devices, Radiofrequency (RF) Devices, Neurostimulation Devices, Punctal Occlusion Devices, Eyelid Debridement & Blepharitis Treatment Devices and Others. Based on application, the market is segmented into Meibomian Gland Dysfunction (MGD) Treatment, Evaporative Dry Eye Treatment, Aqueous Deficient Dry Eye Treatment, Blepharitis-Associated Dry Eye Management and Ocular Surface Inflammation Management. Based on portability, the market is segmented into Standalone Clinical Systems, Handheld/Portable Devices and Home-Use Devices. Based on end user, the market is segmented into Hospitals, Ophthalmology Clinics, Optometry Clinics, Ambulatory Surgical Centers (ASCs) and Home Care Settings. Based on distribution channel, the market is segmented into Direct Sales, Distributors & Dealers and Online Sales Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dry Eye Treatment Devices Market

The growing incidence of dry eye is significantly driving the demand for both diagnostic and therapeutic devices, as an increasing number of individuals seek clinical assistance for symptom management. When the discomfort from dry eye affects daily activities, healthcare professionals intensify their efforts to identify and treat the condition, leading clinics to acquire specialized equipment, often unplanned. This heightened focus on dry eye management fosters greater recognition and facilitates natural investment in device procurement. Consequently, manufacturers are motivated to innovate user-friendly solutions, creating a responsive cycle that promotes continuous product development and commercialization, ensuring availability and addressing the ever-growing clinical needs effectively.

Restraints in the Global Dry Eye Treatment Devices Market

The Global Dry Eye Treatment Devices market faces significant restraints due to the high costs associated with advanced treatment devices. This financial burden restricts adoption among clinics and patients, particularly when budgets are constrained, leading to challenges in affordability. Consequently, procurement decisions are prolonged, hindering the broader implementation of these solutions. Smaller practices might opt to defer investments in specialized equipment, relying instead on more conservative treatments, which further limits device penetration in various healthcare settings. Additionally, cost sensitivity affects discussions around reimbursement and influences purchasing decisions within healthcare organizations, ultimately resulting in uneven market uptake and increased pressure on manufacturers to demonstrate value and provide flexible pricing options.

Market Trends of the Global Dry Eye Treatment Devices Market

The Global Dry Eye Treatment Devices market is experiencing a significant transformation driven by the rise of telehealth-enabled care models. With the advent of remote check-ins and connected diagnostic tools, patients are gaining access to more convenient and effective dry eye management options. This shift allows clinicians to remotely triage symptoms, adjust device usage, and monitor adherence via digital platforms, fostering personalized care and timely interventions. The increased adoption of at-home therapeutic devices alleviates traditional barriers to specialist consultations, promoting collaborative treatment pathways between optometrists and ophthalmologists. Ultimately, this trend enhances patient convenience and improves long-term management outcomes for diverse patient populations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Dry Eye Treatment Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Thermal Pulsation Devices
• Intense Pulsed Light (IPL) Devices
• Broadband Light (BBL) Devices
• Meibomian Gland Expression (MGX) Systems
• Combination Therapy Devices (IPL + MGX / Heat + Expression)
• Low-Level Light Therapy (LLLT) Devices
• Radiofrequency (RF) Devices
• Neurostimulation Devices
• Punctal Occlusion Devices
• Eyelid Debridement & Blepharitis Treatment Devices
• Others

Global Dry Eye Treatment Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Meibomian Gland Dysfunction (MGD) Treatment
• Evaporative Dry Eye Treatment
• Aqueous Deficient Dry Eye Treatment
• Blepharitis-Associated Dry Eye Management
• Ocular Surface Inflammation Management

Global Dry Eye Treatment Devices Market Size by Portability & CAGR (2026-2033)

• Market Overview
• Standalone Clinical Systems
• Handheld/Portable Devices
• Home-Use Devices

Global Dry Eye Treatment Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ophthalmology Clinics
• Optometry Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings

Global Dry Eye Treatment Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors & Dealers
• Online Sales Channels

Global Dry Eye Treatment Devices Market Size & CAGR (2026-2033)

• North America (Technology, Application, Portability, End User, Distribution Channel)
  • US
  • Canada
• Europe (Technology, Application, Portability, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Portability, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Portability, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Portability, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Lumenis Be Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision Care, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sight Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TearScience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESW Vision Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantel Medical SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optima Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IRIDEX Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyevance Pharmaceuticals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aequus Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCuSOFT Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiBo Medical Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuSight Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruder Healthcare Company LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations